Cat.#: ACPP-1290
| Despition | Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1741 | Human NDRG1 Protein (AC1741) | 10 µg | inquiry |
| ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
| ACPP-1406 | Human Recoverin Protein (AC1406) | 10 µg | inquiry |
| ACPP-1628 | Human LIF Protein, GST (AC1628) | 2 µg | inquiry |
| ACPP-1190 | ADCY6 Blocking Peptide (AC1190) | 250 µg | inquiry |
| ACPP-1690 | Human PDE6H Protein (AC1690) | 2 µg | inquiry |
| ACPP-1670 | Mouse BDNF Protein (AC1670) | 2 µg | inquiry |
| ACPP-1215 | PINK1 Blocking Peptide (AC1215) | 250 µg | inquiry |
| ACPP-1778 | Human HSD17B10 Protein (AC1778) | 2 µg | inquiry |
| ACPP-1197 | Dopamine Transporter Blocking Peptide (AC1197) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.